Back to overview
André Bergman group
André Bergman studied Medicine and
Biology at the VU University in Amsterdam. In 2002 he obtained his
PhD from the same university (Prof H Pinedo and Prof G Peters).
During his PhD he studied the mechanisms of resistance to the
anti-cancer deoxynucleoside gemcitabine. Part of this research was
done at Yale University, New Haven, USA. From 1999 on he was
trained in Internal Medicine at the University of Utrecht and
subsequently as a Medical Oncologist at VU University in Amsterdam.
After being registered as a Medical Oncologist, he received a
fellowship from the Dutch Cancer Society (KWF). During this
fellowship he worked one year in the lab of Prof A Berns at the
Netherlands Cancer Institute and one year in the lab of Prof W
Nelson, Sidney Kimmel Cancer Center, Johns Hopkins Medical
Institutions, Baltimore, USA. Since 2008 he works as a Medical
Oncologist at the Antoni van Leeuwenhoek hospital, with a special
interest in treating urogenital cancers. After receiving a personal
grant from KWF in 2009, a research group was formed exploring the
role of the microenvironment in prostate cancer development.